TOBRAMYCIN IN RENAL IMPAIRMENT

被引：28

作者：

BECHTOL, LD ^{[1
]}

BLACK, HR ^{[1
]}

机构：

[1] MARION CTY GEN HOSP,LILLY LAB CLIN RES,960 LOCKE ST,INDIANAPOLIS,IN 46202

来源：

AMERICAN JOURNAL OF THE MEDICAL SCIENCES | 1975年 / 269卷 / 03期

关键词：

D O I：

10.1097/00000441-197505000-00004

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：317 / 321

页数：5

共 12 条

[1]

BROGARD JM, 1974, L NOUVELLE PRESS S17, V3, P59

[2]

BRUMMETT RE, 1972, ARCHIV OTOLARYNGOL, V96, P505

[3]

DETTLI L, 1971, ACTA PHARMACOL TOX, V29, P211

[4] CLINICAL PHARMACOLOGY OF TOBRAMYCIN [J].

HORIKOSHI, N ;

VALDIVIESO, M ;

BODEY, GP .

AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1973, 266 (06) :453-458

[5] TOBRAMYCIN AND GENTAMICIN CONCENTRATIONS IN SERUM OF NORMAL AND ANEPHRIC PATIENTS [J].

LOCKWOOD, WR ;

BOWER, JD .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1973, 3 (01) :125-129

[6]

MCHENRY M C, 1974, Clinical Pharmacology and Therapeutics, V15, P213

[7] PHARMACOLOGIC STUDIES ON TOBRAMYCIN AND COMPARISON WITH GENTAMICIN [J].

MEYERS, BR ;

HIRSCHMAN, SZ .

JOURNAL OF CLINICAL PHARMACOLOGY AND NEW DRUGS, 1972, 12 (8-9) :321-+

[8] PHARMACOKINETICS OF AMINOGLYCOSIDE ANTIBIOTIC TOBRAMYCIN IN HUMANS [J].

NABER, KG ;

WESTENFELDER, SR ;

MADSEN, PO .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1973, 3 (04) :469-473

[9]

REGAMEY C, 1973, CLIN PHARMACOL THER, V14, P396

[10]

ROSA FD, 1974, J INT MED RES, V2, P100

← 1 2 →